Director LC-MS Biologics & Biomarkers
Q2 Solutions
Ithaca, New York
Barry Jones leads the large molecule LC/MS team at Q2 Solutions. After receiving his PhD in Physical Chemistry from Binghamton University, Barry led the University’s Mass Spectrometer Core facility for proteomic research until joining Q2 Solutions (then Advion) in 2007. Research within the LC/MS biologics group at Q2 Solutions is focused on targeted quantitative LC/MS analysis of endogenous biomolecules and large molecule biotherapeutics on triple quadrupole and orbitrap instruments. Dr. Jones is particularly interested in the application of hybrid Immunoaffinity-LC/MS, high resolution mass spectrometry, and low-flow chromatography techniques to drive sensitivity and selectivity of high-throughput, regulated bioanalytical methods, as well as the scientific challenges and validation strategies for LC/MS biomarker assays supporting drug development.
Disclosure information not submitted.
Monday, October 17, 2022
3:00 PM – 4:00 PM ET